Report the occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera.

results suggest that annexin-1, annexin-2, and annexin-3 are identified as potential biomarkers associated with lymph node metastasis in lung adenocarcinoma

Data show that hypoxia upregulates the expression of Annexin A1 in lung adenocarcinoma A549 cells, in which process reactive oxygen species (ROS)-NF-kappaB may paticipate in.

The upregulation of annexin A1 was associated with poor post-surgical survival time and lymphatic metastasis of lung cancer patients

The expression levels of Hsp90-beta and annexin A1 positively correlated and such co-overexpression of Hsp90-beta and annexin A1 contributed to lung cancer diagnosis.

Data show that elevated levels of annexin A1 are associated with small cell lung cancer {SCLC) brain metastasis.

High ANXA1 expression is associated with lymphatic invasion and malignant progression of lung cancer.

Circulating IgG antibodies to ANXA1 could be used as a biomarker for early diagnosis of non-small cell lung carcinoma.

Results find that ANXA1 promotes the migration and invasion of non-small cell lung cancer (NSCLC) through positive regulation of NF-kappaB activation. Its overexpression correlates with a more aggressive clinical course and a significantly shorter survival.

Upregulation of annexin A1 protein expression in the intratumoral vasculature of human non-small-cell lung carcinoma and rodent tumor models.

AnxA1 knockdown in invasive basal-like breast cancer cells reduced the number of spontaneous lung metastasis, whereas additional expression of AnxA1 enhanced metastatic spread.